id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289114-ifnk41oq	Singh, Angaraj	Effect of pre‐existing diseases on COVID‐19 infection and role of new sensors and biomaterials for its detection and treatment	2020-10-28		.txt	text/plain	6894	470	54	The SARS-CoV-2 infected patients with the cardiovascular problem have a higher fatality rate as compared to general COVID-19 patients. The ACE-2 has been suggested as a medicine for the treatment of diabetes because it reduces inflammation .Therefore, the diabetes and COVID-19 patients treated with ACE-2 have higher risk of infection (Zachary, 2020) . Although, the specific drug for SARS-CoV-2 is not discovered till date, the medical observers are attempting with different antiviral drugs for the treatment of COVID-19 infection . All rights reserved patients demonstrated that the combination of a new antiviral drug remdesivir and chloroquine slowed down the growth of SARS-CoV-2 (Abdul et al., 2017) . Convalescent plasma therapy has been observed as a better alternative for the treatment of severely infected COVID-19 patients. A research report suggested that plasma treatment is more effective at the initial stage (within 14 days of symptoms) of COVID-19 infection.	./cache/cord-289114-ifnk41oq.txt	./txt/cord-289114-ifnk41oq.txt